Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.

[1]  D. Sriram,et al.  Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis. , 2019, European journal of medicinal chemistry.

[2]  D. Sriram,et al.  Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. , 2019, Bioorganic & medicinal chemistry letters.

[3]  Luke W. Guddat,et al.  Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads , 2019, Journal of Computer-Aided Molecular Design.

[4]  P. Yogeeswari,et al.  Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies , 2018, Steroids.

[5]  D. Sriram,et al.  Rational design of coumarin derivatives as antituberculosis agents. , 2018, Future Medicinal Chemistry.

[6]  D. Sriram,et al.  A Quinoline Compound Inhibits the Replication of Dengue virus Serotypes 1–4 in Vero Cells , 2018, Antiviral therapy.

[7]  L. Guddat,et al.  Metal Ions Play an Essential Catalytic Role in the Mechanism of Ketol-Acid Reductoisomerase. , 2016, Chemistry.

[8]  L. Guddat,et al.  Crystal structure of Mycobacterium tuberculosis ketol‐acid reductoisomerase at 1.0 Å resolution – a potential target for anti‐tuberculosis drug discovery , 2016, The FEBS journal.

[9]  N. S. Mahajan,et al.  Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis. , 2015, European journal of medicinal chemistry.

[10]  P. Yogeeswari,et al.  Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives. , 2015, European journal of medicinal chemistry.

[11]  Nicola J. Ryan,et al.  Delamanid: First Global Approval , 2014, Drugs.

[12]  Se Yeon Kim,et al.  Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis , 2013, Nature Medicine.

[13]  Beena,et al.  Antituberculosis Drug Research: A Critical Overview , 2013, Medicinal research reviews.

[14]  Zhen Liu,et al.  Discovery of Novel Acetohydroxyacid Synthase Inhibitors as Active Agents against Mycobacterium tuberculosis by Virtual Screening and Bioassay , 2013, J. Chem. Inf. Model..

[15]  D. Ehmann,et al.  Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile. , 2012, Journal of medicinal chemistry.

[16]  G. Hatfull,et al.  Growth of Mycobacterium tuberculosis biofilms. , 2012, Journal of visualized experiments : JoVE.

[17]  Thomas R. Ioerger,et al.  High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism , 2011, PLoS pathogens.

[18]  K. Dill,et al.  Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". , 2009, Structure.

[19]  Amita Jain,et al.  Extensively drug-resistant tuberculosis: current challenges and threats. , 2008, FEMS immunology and medical microbiology.

[20]  K. Bhusari,et al.  QSAR studies on 4-thiazolidinones and 2-azetidinones bearing benzothiophene nucleus as potential anti-tubercular agents , 2008 .

[21]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[22]  Fabrizio Manetti,et al.  Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. , 2006, Journal of medicinal chemistry.

[23]  Moon-Young Yoon,et al.  Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library , 2005, FEBS letters.

[24]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[25]  S. Croft,et al.  Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead. , 2003, Journal of medicinal chemistry.

[26]  J. Betts,et al.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling , 2002, Molecular microbiology.

[27]  D. Kell,et al.  Culturability of Mycobacterium tuberculosis cells isolated from murine macrophages: a bacterial growth factor promotes recovery. , 2000, FEMS immunology and medical microbiology.

[28]  L. Collins,et al.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.

[29]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[30]  K. Calvo,et al.  Mechanism of ketol acid reductoisomerase--steady-state analysis and metal ion requirement. , 1989, Biochemistry.

[31]  T. Chiba,et al.  [Synthesis of 2(or 2,5-di)-substituted-1,3,4-thiadiazole derivatives]. , 1965, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.